Related references
Note: Only part of the references are listed.Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
Jean D. Sipe et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Bis(indolyl)phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme
Hassan Ramshini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies
Roberta Cascella et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Current and future treatment of amyloid diseases
M. Ankarcrona et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Environmentally friendly cyclotrimerization of substituted acetophenones catalyzed by a new nanocomposite of γ-Al2O3 nanoparticles decorated with H5PW10V2O40
Reza Tayebee et al.
RSC ADVANCES (2016)
Aromaticity and amyloid formation: Effect of π-electron distribution and aryl substituent geometry on the self-assembly of peptides derived from hIAPP22-29
Adam A. Profit et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease
Xiao-Qin Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease
Zhipei Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Inhibition of amyloid fibril formation and cytotoxicity by a chemical analog of Curcumin as a stable inhibitor
Hassan Ramshini et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
A new method for the preparation of 1,3,5-triarylbenzenes catalyzed by nanoclinoptilolite/HDTMA
R. Tayebee et al.
RSC ADVANCES (2015)
H6P2W18O62/Nanoclinoptilolite as an efficient nanohybrid catalyst in the cyclotrimerization of aryl methyl ketones under solvent-free conditions
R. Tayebee et al.
RSC ADVANCES (2015)
Polyphenols as Therapeutic Molecules in Alzheimer's Disease Through Modulating Amyloid Pathways
Johant Lakey-Beitia et al.
MOLECULAR NEUROBIOLOGY (2015)
Chemical kinetics for drug discovery to combat protein aggregation diseases
Paolo Arosio et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
Mustafa T. Ardah et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Evidence of π-stacking interactions in the self-assembly of hIAPP22-29
Adam A. Profit et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2013)
Natural Biomolecules and Protein Aggregation: Emerging Strategies against Amyloidogenesis
Antonella Sgarbossa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Hydrophobic, Aromatic, and Electrostatic Interactions Play a Central Role in Amyloid Fibril Formation and Stability
Karen E. Marshall et al.
BIOCHEMISTRY (2011)
Mutations That Replace Aromatic Side Chains Promote Aggregation of the Alzheimer's Aβ Peptide
Anne H. Armstrong et al.
BIOCHEMISTRY (2011)
A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes
Ejaz Ahmad et al.
BIOCHIMIE (2011)
Alzheimer's Disease Drug Candidates Stabilize A-β Protein Native Structure by Interacting with the Hydrophobic Core
Jie Li et al.
BIOPHYSICAL JOURNAL (2011)
Prediction of amyloid aggregation in vivo
Mattia Belli et al.
EMBO REPORTS (2011)
The role of aromatic side-chains in amyloid growth and membrane interaction of the islet amyloid polypeptide fragment LANFLVH
Danilo Milardi et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2011)
Amyloid-β: The seeds of darkness
Michelle T. Fodero-Tavoletti et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid β through Three Independent Pathways
Ali Reza A. Ladiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer's Disease
F. Re et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution
Shuichiro Goda et al.
PROTEIN SCIENCE (2010)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
An Analytical Solution to the Kinetics of Breakable Filament Assembly
Tuomas P. J. Knowles et al.
SCIENCE (2009)
Targeting insulin amyloid assembly by small aromatic molecules Toward rational design of aggregation inhibitors
Michal Levy-Sakin et al.
ISLETS (2009)
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
Aynun N. Begum et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility
Ashley A. Reinke et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Amyloid-forming propensity of the hydrophobic non-natural amino acid on the fibril-forming core peptide of human tau
Akiyoshi Hirata et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
A three-stage kinetic model of amyloid fibrillation
Chuang-Chung Lee et al.
BIOPHYSICAL JOURNAL (2007)
The first step of hen egg white lysozyme fibrillation, irreversible partial unfolding, is a two-state transition
Ming Xu et al.
PROTEIN SCIENCE (2007)
Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology
Peter Marek et al.
BIOCHEMISTRY (2007)
Silicagel-supported H6P2W18O62.24H(2)O: a reusable catalyst to prepare diphenylmethyl (DPM) ethers
Gustavo P. Romanelli et al.
ARKIVOC (2007)
Prefibrillar amyloid aggregates could be generic toxins in higher organisms
Serena Baglioni et al.
JOURNAL OF NEUROSCIENCE (2006)
Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase
F Bemporad et al.
PROTEIN SCIENCE (2006)
Molecular basis for amyloid fibril formation and stability
OS Makin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Formation of amyloid fibrils from fully reduced hen egg white lysozyme
AE Cao et al.
PROTEIN SCIENCE (2004)
Techniques to study amyloid fibril formation in vitro
MR Nilsson
METHODS (2004)
Role of aromatic interactions in amyloid formation by peptides derived from human amylin
SM Tracz et al.
BIOCHEMISTRY (2004)
The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates
GG Tartaglia et al.
PROTEIN SCIENCE (2004)
Rationalization of the effects of mutations on peptide and protein aggregation rates
F Chiti et al.
NATURE (2003)
Completely different amyloidogenic potential of nearly identical peptide fragments
Y Porat et al.
BIOPOLYMERS (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Therapeutic strategies for human amyloid diseases
JC Sacchettini et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a β-sheet breaker peptide
B Permanne et al.
FASEB JOURNAL (2002)
A possible role for pi-stacking in the self-assembly of amyloid fibrils
E Gazit
FASEB JOURNAL (2002)
Analysis of the structural and functional elements of the minimal active fragment of islet amyloid polypeptide (IAPP) - An experimental support for the key role of the phenylalanine residue in amyloid formation
R Azriel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain
MRH Krebs et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants
LA Morozova-Roche et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Inhibiting the conversion of soluble amyloid-beta peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy
C Soto et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Share Paper
